Two phase 3 trials of bimekizumab for the treatment of moderate-to-severe hidradenitis suppurativa: a critically appraised research paper.
No Thumbnail Available
Authors
McCarthy R.
Ring, H. C.
Contact
Check for full-text access
Issue Date
2026
Type
Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Publisher
License
Journal
The British journal of dermatology
